Tissue Regenix Group Regulatory News (TRX)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

John Samuel

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tissue Regenix Group plc

b)

LEI

213800PNOD5UHQUFJI36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

GB00B5SGVL29

b)

Nature of the transaction

Subscription for ordinary shares

c)

Price(s) and volume(s)

d)

Aggregated information

N/A

e)

Date of the transaction

9 August 2017

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alan Miller

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tissue Regenix Group plc

b)

LEI

213800PNOD5UHQUFJI36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

GB00B5SGVL29

b)

Nature of the transaction

Subscription for ordinary shares

c)

Price(s) and volume(s)

d)

Aggregated information

N/A

e)

Date of the transaction

9 August 2017

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Antony Odell

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tissue Regenix Group plc

b)

LEI

213800PNOD5UHQUFJI36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

GB00B5SGVL29

b)

Nature of the transaction

Subscription for ordinary shares

c)

Price(s) and volume(s)

d)

Aggregated information

N/A

e)

Date of the transaction

9 August 2017

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonathan Glenn

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tissue Regenix Group plc

b)

LEI

213800PNOD5UHQUFJI36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

GB00B5SGVL29

b)

Nature of the transaction

Subscription for ordinary shares

c)

Price(s) and volume(s)

d)

Aggregated information

N/A

e)

Date of the transaction

9 August 2017

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul Devlin

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tissue Regenix Group plc

b)

LEI

213800PNOD5UHQUFJI36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

GB00B5SGVL29

b)

Nature of the transaction

Subscription for ordinary shares

c)

Price(s) and volume(s)

d)

Aggregated information

N/A

e)

Date of the transaction

9 August 2017

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Steven Couldwell

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tissue Regenix Group plc

b)

LEI

213800PNOD5UHQUFJI36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

GB00B5SGVL29

b)

Nature of the transaction

Subscription for ordinary shares

c)

Price(s) and volume(s)

d)

Aggregated information

N/A

e)

Date of the transaction

9 August 2017

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Shervanthi Homer Vanniasinkam

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tissue Regenix Group plc

b)

LEI

213800PNOD5UHQUFJI36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

GB00B5SGVL29

b)

Nature of the transaction

Subscription for ordinary shares

c)

Price(s) and volume(s)

d)

Aggregated information

N/A

e)

Date of the transaction

9 August 2017

f)

Place of the transaction

Outside a trading venue